Physician-scientists at IU School of Medicine conduct ground-breaking research to understand drug-induced liver injury.

Drug-induced Liver Injury Research Studies

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has established the Drug-Induced Liver Injury Network (DILIN) to collect and analyze cases of severe liver injury caused by prescription drugs, over-the-counter drugs, and alternative medicines, such as herbal products.

Investigator

Naga P. Chalasani, MD

David W. Crabb Professor of Gastroenterology and Hepatology

Open Research Studies for Drug-induced Liver Injury

Prospective DILIN

Enrolling: Yes

Principal Investigator: Naga Chalasani, MD

Duration: 6 - 24 months

Patient Population: NAS > 4

Interested in this study? Please contact the clinical liver research team: iuliverr@iu.edu

View the study on clinicaltrials.gov

Prospective Acute DILIN

Enrolling: Yes

Principle Investigator: Naga Chalasani, MD

Duration: 6 - 24 months

Patient Population: DILI enrolled within 16 days of date of onset

Interested in this study? Please contact the clinical liver research team: iuliverr@iu.edu

Retrospective Acute DILIN

Enrolling: Yes

Principal Investigator: Naga Chalasani, MD

Duration: 6 - 24 months

Patient Population: NAS > 4

Interested in this study? Please contact the clinical liver research team: iuliverr@iu.edu